Skip to contentApplication 214522
- Type
- NDA
- Sponsor
- CMP DEV LLC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TADLIQ | TADALAFIL | SUSPENSION;ORAL | 20MG/5ML | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 46287-045 | TADLIQ | Tadalafil | CMP Pharma, Inc. | NDA | Current |
| 46287-045 | TADLIQ | Tadalafil | CMP Pharma, Inc. | NDA | Current |
| 46287-045 | TADLIQ | Tadalafil | CMP Pharma, Inc. | NDA | Current |
| 46287-045 | TADLIQ | Tadalafil | CMP Pharma, Inc. | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 73561 | ORIG | 2023-02-21 |
| 71416 | ORIG | 2022-06-21 |
| 71384 | ORIG | 2022-06-21 |